Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

InMed Pharmaceuticals Inc. (INM) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

InMed Pharmaceuticals Inc. and Shuttle Pharmaceuticals Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Shuttle Pharmaceuticals Holdings, Inc. is the larger, with a market value of $15.6M against $7.7M — 2.0× the size. InMed Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Shuttle Pharmaceuticals Holdings, Inc. trades at 34.7×. Across the 10 metrics below, InMed Pharmaceuticals Inc. leads on 5 and Shuttle Pharmaceuticals Holdings, Inc. on 5.

Valuation

Metric INM SHPH Drug Manufacturers Specialty & Generic median
P/E n/m 34.75 20.14
P/S 1.00 n/m 2.25
P/B 5.35 0.60 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.65 n/m 2.56
Earnings yield (218.43%) 2.88% (2.99%)
Free cash flow yield (151.13%) (467.78%) 0.00%

Profitability

Metric INM SHPH Drug Manufacturers Specialty & Generic median
Gross margin 26.27% 0.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (179.09%) (326.36%) (0.40%)
Return on assets (139.63%) (126.42%) (3.32%)
Return on invested capital 0.00% (309.75%) 0.00%

Growth

Metric INM SHPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 19.38% — 10.01%
EPS growth (last fiscal year) 62.68% 91.32% —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INM SHPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 1.37 0.30 2.31
Net debt to EBITDA 0.20 0.03 0.85

Dividend

Metric INM SHPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric INM SHPH Drug Manufacturers Specialty & Generic median
Market cap 7.69m 15.59m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack